• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Ugur Sahin
Biotech

BioNTech's CEO, CMO will depart to set up next-gen mRNA company

BioNTech’s CEO Uğur Şahin, M.D., and his fellow co-founder and wife Özlem Türeci, M.D., will depart the mRNA powerhouse by the end of the year.
James Waldron Mar 10, 2026 6:30am
An abstract image of data

ARPA-H kicks off wearable biosensor development program

Mar 10, 2026 1:59pm
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
no longer in business sign

Molecular glue biotech f5 Therapeutics closes down

Mar 10, 2026 1:10pm
The flags of South Korea and the United States

Lilly pledges $500M to South Korea biopharma industry

Mar 10, 2026 12:00pm
Go sign green light

FDA reconsidering Capricor’s snubbed DMD cell therapy

Mar 10, 2026 11:14am
More News

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

Mar 10, 2026 11:10am

Fierce Biotech Layoff Tracker 2026: f5 Tx, Vertex & more

Mar 10, 2026 11:00am

Medtronic to drop $550M for Scientia and its stroke care catalog

Mar 10, 2026 10:34am

Voyager pauses Alzheimer's program 8 months after unveiling med

Mar 10, 2026 10:20am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings